Home > Past Lab Members

|
Carlo Fremd was a visiting medical student from Heidelberg University, Germany. He joined the lab from December 2011 to September 2012 to gain experience in basic gynecological research. He also participated to clinical rotations in the University Hospital of Penn. |
![]() |
Timothy (Tim) Chao was a 1st year MD. Ph.D. student from Penn. He joined the lab during the summer 2012 to work on the role of B cells in ovarian cancer and teamed up with Carlo. |
Selene Nunez-Cruz, PhD, joined the OCRC as postdoctoral researcher in 2008 after a first post-doctoral fellowship at the Children's Hospital of Philadelphia. She became a Research Associate from 2010 to 2012. Selene’s project was centered on the role of complement system proteins and B cells in ovarian cancer. She developped several mouse models to conduct these studies. Her work was published and recompensed by several presentation awards in international meetings.
![]() |
Denarda Dangaj worked on her thesis project from 2008 to 2012, after obtaining a BS in Molecular Biology & Genetics from the University of Thrace, Greece, in 2007. During her thesis project, she first studied the role of GPI-anchored glycoproteins in macrophage polarization in tumor stroma. Toward this goal, Denada developed in vitro model systems for human macrophage maturation and generating recombinant proteins, antigen-specific yeast-display scFv and biobodies. Next, Denarda developed and validated recombinant antibodies directed against B7-H4 immunosuppressive molecule.
|
Matthew Cha, Kevin Chu, Andrew Lee, and Xiao Ling were Bioengineering Undergraduate Students when they worked in the Scholler lab for their Senior Design Project during the spring of 2011. They formed the KMAX team. They were developing nanoparticles capable of binding ovarian cancer cells via recombinant antibodies for inductive heating and thermoablation of cancer cells. |
||
Caroline Rozan (second left), here with Selene, Shree and Yi (left to right).Caroline was a PhD student from the INSERM laboratory of Daniel Baty in Marseille Luminy, France. She came during the summer 2010 for a collaborative study centered on the development of bispecific antibodies directed against CEA and CD16.
Nicole Martinez was a graduate student in the Iimmunology program at Penn when she spent a lab rotation during the spring of 2010 in the Scholler lab. She wrote: "Rotating in the Scholler lab allowed me to engage in exciting research at the forefront of developing novel ovarian cancer immunotherapies. This conducive environment allowed me to gain field-specific knowledge as well as develop exceptional experimental design strategies and an “out of the box” approach to problem solving that are beneficial to my career." |
Ananda Mookerjee obtained his PhD degree in immunology in 2005 from the Bose Institute, Kolkata, India. He received two post doctoral trainings, first in the Chittaranjan National Cancer Institute, Kolkata, India and the second at U563, INSERM, Purpan in Toulouse, France before he joined UPenn in 2010 as a post-doctoral fellow. He spent one year working in the Scholler lab, characterizing the tumor microenvironment of an humanized mouse model. |
Natalia Diaz-Rodriguez was a third year student at the University of Pennsylvania Perelman School of Medicine when she worked at the Scholler lab during the summer of 2009. Under the guidance of Dr. Zhao and Dr. Scholler, Natalia worked on screening and isolating a scFv antibody library against formalin-fixed, murine and human mesothelin. |
|
Aizhi Zhao, MD, PhD, was a post-doctoral fellow from 2008 to 2010 in the Scholler lab. Aizhi constructed two yeast-display antibody libraries and identified affinity reagents against tumor vasculature specific markers for diagnostic, imaging and therapeutic applications. Aizhi is now Research Associate at Penn OCRC. |
|
Amber Roberts, MS, was a research specialist in the Scholler lab from 2008 to 2009. She was assisting the researchers with writing and submitting IACUC research protocols and oversaw related compliance matters.
Murielle Saade (right) visited our lab for a couple of months at the beginning of the year 2008. She was then a graduate student from the group of Catherine N'Guyen at the TAGC in Marseille, France. She learned our yeast-display technology and brought it back to her lab. She is now a post-doctoral fellow in Barcelona, Spain. On the picture she is with Dimitra Sasaroli (left), then a PhD visiting student from Greece in the laboratory of Dr G. Coukos. |
Sanjiban Banerjee (right) was a post-doctoral fellow in the TOR laboratory at the FHCRC, where he was initiated by Dr Scholler to recombinant antibodies expressed by yeast. Since then, he moved back to India and created AbGenics Life Sciences, a start up biotech company based in Pune (India). Its research programs evolve from the convergence of the remarkable specificity, flexibility and diversity of the antibody molecules. The mission forward at AbGenics is to further harness and modulate the potential of antibody molecules for prophylaxis and treatment of infectious diseases.